The Lancet, the respected medical journal, is now retracting the key study that cast doubt on the safety of hydroxychloroquine. The anti-malaria drug is being researched as a potential treatment for COVID-19. Heather Yourex-West explains the dispute over some flawed data, and the pitfalls of rushing research.
- Global trial of hydroxychloroquine as coronavirus treatment to resume
- The Lancet retracts hydroxychloroquine study following data concerns
- Medical journal questioning findings of hydroxychloroquine coronavirus study